BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 33426150)

  • 1. A human surfactant B deficiency air-liquid interface cell culture model suitable for gene therapy applications.
    Munis AM; Hyde SC; Gill DR
    Mol Ther Methods Clin Dev; 2021 Mar; 20():237-246. PubMed ID: 33426150
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RNA-seq analysis of the human surfactant air-liquid interface culture reveals alveolar type II cell-like transcriptome.
    Munis AM; Wright B; Jackson F; Lockstone H; Hyde SC; Green CM; Gill DR
    Mol Ther Methods Clin Dev; 2022 Mar; 24():62-70. PubMed ID: 34977273
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene Therapy Potential for Genetic Disorders of Surfactant Dysfunction.
    Cooney AL; Wambach JA; Sinn PL; McCray PB
    Front Genome Ed; 2021; 3():785829. PubMed ID: 35098209
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correction of a chronic pulmonary disease through lentiviral vector-mediated protein expression.
    Lund-Palau H; Juarez-Molina CI; Meng C; Bhargava A; Pilou A; Aziz K; Clarke N; Atsumi N; Ashek A; Wilson MR; Takata M; Padley S; Gill DR; Hyde SC; Morgan C; Alton EWFW; Griesenbach U
    Mol Ther Methods Clin Dev; 2022 Jun; 25():382-391. PubMed ID: 35573048
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of F/HN-pseudotyped lentivirus as a clinically relevant vector for lung gene therapy.
    Griesenbach U; Inoue M; Meng C; Farley R; Chan M; Newman NK; Brum A; You J; Kerton A; Shoemark A; Boyd AC; Davies JC; Higgins TE; Gill DR; Hyde SC; Innes JA; Porteous DJ; Hasegawa M; Alton EW
    Am J Respir Crit Care Med; 2012 Nov; 186(9):846-56. PubMed ID: 22955314
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sendai F/HN pseudotyped lentiviral vector transduces human ciliated and non-ciliated airway cells using α 2,3 sialylated receptors.
    Munday RJ; Coradin T; Nimmo R; Lad Y; Hyde SC; Mitrophanos K; Gill DR
    Mol Ther Methods Clin Dev; 2022 Sep; 26():239-252. PubMed ID: 35892086
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reversal of Surfactant Protein B Deficiency in Patient Specific Human Induced Pluripotent Stem Cell Derived Lung Organoids by Gene Therapy.
    Leibel SL; Winquist A; Tseu I; Wang J; Luo D; Shojaie S; Nathan N; Snyder E; Post M
    Sci Rep; 2019 Sep; 9(1):13450. PubMed ID: 31530844
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The murine lung as a factory to produce secreted intrapulmonary and circulatory proteins.
    Paul-Smith MC; Pytel KM; Gelinas JF; McIntosh J; Pringle I; Davies L; Chan M; Meng C; Bell R; Cammack L; Moran C; Cameron L; Inoue M; Tsugumine S; Hironaka T; Gill DR; Hyde SC; Nathwani A; Alton EWFW; Griesenbach U
    Gene Ther; 2018 Aug; 25(5):345-358. PubMed ID: 30022127
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lung endothelial cells strengthen, but brain endothelial cells weaken barrier properties of a human alveolar epithelium cell culture model.
    Neuhaus W; Samwer F; Kunzmann S; Muellenbach RM; Wirth M; Speer CP; Roewer N; Förster CY
    Differentiation; 2012 Nov; 84(4):294-304. PubMed ID: 23023065
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preparation for a first-in-man lentivirus trial in patients with cystic fibrosis.
    Alton EW; Beekman JM; Boyd AC; Brand J; Carlon MS; Connolly MM; Chan M; Conlon S; Davidson HE; Davies JC; Davies LA; Dekkers JF; Doherty A; Gea-Sorli S; Gill DR; Griesenbach U; Hasegawa M; Higgins TE; Hironaka T; Hyndman L; McLachlan G; Inoue M; Hyde SC; Innes JA; Maher TM; Moran C; Meng C; Paul-Smith MC; Pringle IA; Pytel KM; Rodriguez-Martinez A; Schmidt AC; Stevenson BJ; Sumner-Jones SG; Toshner R; Tsugumine S; Wasowicz MW; Zhu J
    Thorax; 2017 Feb; 72(2):137-147. PubMed ID: 27852956
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A promoterless AAV6.2FF-based lung gene editing platform for the correction of surfactant protein B deficiency.
    Thomas SP; Domm JM; van Vloten JP; Xu L; Vadivel A; Yates JGE; Pei Y; Ingrao J; van Lieshout LP; Jackson SR; Minott JA; Achuthan A; Mehrani Y; McAusland TM; Zhang W; Karimi K; Vaughan AE; de Jong J; Kang MH; Thebaud B; Wootton SK
    Mol Ther; 2023 Dec; 31(12):3457-3477. PubMed ID: 37805711
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tissue-specific, tumor-selective, replication-competent adenovirus vector for cancer gene therapy.
    Doronin K; Kuppuswamy M; Toth K; Tollefson AE; Krajcsi P; Krougliak V; Wold WS
    J Virol; 2001 Apr; 75(7):3314-24. PubMed ID: 11238857
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Co-culture of type I and type II pneumocytes as a model of alveolar epithelium.
    Brookes O; Boland S; Lai Kuen R; Miremont D; Movassat J; Baeza-Squiban A
    PLoS One; 2021; 16(9):e0248798. PubMed ID: 34570783
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Knockdown of Drosha in human alveolar type II cells alters expression of SP-A in culture: a pilot study.
    Silveyra P; Chroneos ZC; DiAngelo SL; Thomas NJ; Noutsios GT; Tsotakos N; Howrylak JA; Umstead TM; Floros J
    Exp Lung Res; 2014 Sep; 40(7):354-66. PubMed ID: 25058539
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lung surfactant metabolism: early in life, early in disease and target in cell therapy.
    Lopez-Rodriguez E; Gay-Jordi G; Mucci A; Lachmann N; Serrano-Mollar A
    Cell Tissue Res; 2017 Mar; 367(3):721-735. PubMed ID: 27783217
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Breaking the in vitro alveolar type II cell proliferation barrier while retaining ion transport properties.
    Bove PF; Dang H; Cheluvaraju C; Jones LC; Liu X; O'Neal WK; Randell SH; Schlegel R; Boucher RC
    Am J Respir Cell Mol Biol; 2014 Apr; 50(4):767-76. PubMed ID: 24191670
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Generating 3D Spheres and 2D Air-Liquid Interface Cultures of Human Induced Pluripotent Stem Cell-Derived Type 2 Alveolar Epithelial Cells.
    Werder RB; Huang J; Abo KM; Hix OT; Minakin K; Alysandratos KD; Merritt C; Berthiaume K; Alber AB; Burgess CL; Kotton DN; Wilson AA
    J Vis Exp; 2022 Apr; (182):. PubMed ID: 35499347
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Triple co-culture of human alveolar epithelium, endothelium and macrophages for studying the interaction of nanocarriers with the air-blood barrier.
    Costa A; de Souza Carvalho-Wodarz C; Seabra V; Sarmento B; Lehr CM
    Acta Biomater; 2019 Jun; 91():235-247. PubMed ID: 31004840
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cis-active elements controlling lung cell-specific expression of human pulmonary surfactant protein B gene.
    Bohinski RJ; Huffman JA; Whitsett JA; Lattier DL
    J Biol Chem; 1993 May; 268(15):11160-6. PubMed ID: 8496176
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alveolar epithelial differentiation of human induced pluripotent stem cells in a rotating bioreactor.
    Ghaedi M; Mendez JJ; Bove PF; Sivarapatna A; Raredon MS; Niklason LE
    Biomaterials; 2014 Jan; 35(2):699-710. PubMed ID: 24144903
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.